These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 445502)
21. Cost-effective treatment of women with advanced ovarian cancer by cytoreductive surgery and chemotherapy directed by an in vitro assay for drug resistance. Orr JW; Orr P; Kern DH Cancer J Sci Am; 1999; 5(3):174-8. PubMed ID: 10367175 [TBL] [Abstract][Full Text] [Related]
22. [An analysis of factors influential in improving the survival rate of patients with ovarian cancer]. Ohta M; Tomoda Y; Kano T Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1008-15. PubMed ID: 2730004 [TBL] [Abstract][Full Text] [Related]
23. Combination chemotherapy with mitomycin C, adriamycin, and cyclophosphamide (MAC) in stage III and IV ovarian cancer. Ratanatharathorn V; Samson MK; Baker LH; Pollard R; Cummings G; Fraile RJ Am J Clin Oncol; 1983 Oct; 6(5):565-70. PubMed ID: 6412538 [TBL] [Abstract][Full Text] [Related]
24. Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply? Moore KN; Reid MS; Fong DN; Myers TK; Landrum LM; Moxley KM; Walker JL; McMeekin DS; Mannel RS Gynecol Oncol; 2008 Aug; 110(2):133-9. PubMed ID: 18495221 [TBL] [Abstract][Full Text] [Related]
25. Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual disease. Edmonson JH; Fleming TR; Decker DG; Malkasian GD; Jorgensen EO; Jefferies JA; Webb MJ; Kvols LK Cancer Treat Rep; 1979 Feb; 63(2):241-7. PubMed ID: 445503 [TBL] [Abstract][Full Text] [Related]
26. [Neoadjuvant chemotherapy for advanced epithelial ovarian cancer]. Hatae M; Onishi Y; Nakamura T; Yamamoto H; Kusumoto M; Matsui T; Mihara K; Taniguchi H Gan To Kagaku Ryoho; 2001 Nov; 28(12):1833-7. PubMed ID: 11729475 [TBL] [Abstract][Full Text] [Related]
27. Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer -- 12-year single center experience. Pavlov MJ; Kovacevic PA; Ceranic MS; Stamenkovic AB; Ivanovic AM; Kecmanovic DM Eur J Surg Oncol; 2009 Nov; 35(11):1186-91. PubMed ID: 19356887 [TBL] [Abstract][Full Text] [Related]
28. [Cytoreductive surgery plus combined chemotherapy for the treatment of advanced ovarian cancer]. Li M; Huang X Zhonghua Fu Chan Ke Za Zhi; 1996 Oct; 31(10):621-3. PubMed ID: 9275460 [TBL] [Abstract][Full Text] [Related]
29. Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary. Dusenbery KE; Bellairs EE; Potish RA; Twiggs LB; Boente MP Gynecol Oncol; 2005 Feb; 96(2):307-13. PubMed ID: 15661213 [TBL] [Abstract][Full Text] [Related]
30. [Cisplatin, adriamycin and cyclophosphamide combination chemotherapy of epithelial ovarian cancer]. Sawada M; Ozaki M; Inagaki M; Hongo J; Hirota Y; Takayama K; Arimoto Y; Wada T; Taki I; Yanagita T Gan To Kagaku Ryoho; 1987 Dec; 14(12):3301-4. PubMed ID: 3120644 [TBL] [Abstract][Full Text] [Related]
35. Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival. Cance WG; Carey LA; Calvo BF; Sartor C; Sawyer L; Moore DT; Rosenman J; Ollila DW; Graham M Ann Surg; 2002 Sep; 236(3):295-302; discussion 302-3. PubMed ID: 12192316 [TBL] [Abstract][Full Text] [Related]
36. Intensive surgical and chemotherapeutic management of advanced ovarian cancer. Griffiths CT; Fuller AF Surg Clin North Am; 1978 Feb; 58(1):131-42. PubMed ID: 417410 [TBL] [Abstract][Full Text] [Related]